Link Details
- Metabolite
- HMDB0000122 (D-Glucose)
- DrugBank ID
- DB09045
- Drug Name
- Dulaglutide
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Jimenez-Solem E, Rasmussen MH, Christensen M, Knop FK: Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes. Curr Opin Mol Ther. 2010 Dec;12(6):790-7. [PubMed:21154170 ]
- Mari A, Del Prato S, Ludvik B, Milicevic Z, de la Pena A, Shurzinske L, Karanikas CA, Pechtner V: Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic beta-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes. Diabetes Obes Metab. 2016 Aug;18(8):834-9. doi: 10.1111/dom.12671. Epub 2016 May 16. [PubMed:27059816 ]
- Terauchi Y, Satoi Y, Takeuchi M, Imaoka T: Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study. Endocr J. 2014;61(10):949-59. Epub 2014 Jul 17. [PubMed:25029955 ]